Axillary Response to Neoadjuvant Therapy in Node-Positive, Estrogen Receptor Positive, HER2 Negative Breast Cancer Patients

被引：0
|
作者：
Friedman-Eldar, O. [1 ]
Ozmen, T. [1 ]
Reyes, F. Valle [1 ]
Goel, N. [1 ]
Tjendra, Y. [1 ]
Moller, M. [1 ]
Kesmodel, S. B. [1 ]
Franceschi, D. [1 ]
Avisar, E. [1 ]
机构：
[1] Univ Miami, Jackson Mem Hosp, Miami, FL 33136 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2021年 / 28卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P59
引用
收藏
页码：S68 / S68
页数：1
相关论文
共 50 条
  • [31] Axillary Lymph Node Status and neoadjuvant Therapy in HER2-positive Breast Cancer
    Danzinger, Autoren S.
    Pfeifer, C.
    Wimmer, S.
    Tendl-Schulz, K.
    Singer, C. F.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2021, 81 (04) : E6 - E6
  • [32] Efficacy of neoadjuvant endocrine therapy compared with neoadjuvant chemotherapy in pre-menopausal patients with oestrogen receptor-positive and HER2-negative, lymph node-positive breast cancer
    Kim, Hee Jeong
    Noh, Woo Chul
    Lee, Eun Sook
    Jung, Yong Sik
    Kim, Lee Su
    Han, Wonshik
    Nam, Seok Jin
    Gong, Gyung-Yub
    Kim, Hwa Jung
    Ahn, Sei Hyun
    BREAST CANCER RESEARCH, 2020, 22 (01)
  • [33] Efficacy of neoadjuvant endocrine therapy compared with neoadjuvant chemotherapy in pre-menopausal patients with oestrogen receptor-positive and HER2-negative, lymph node-positive breast cancer
    Hee Jeong Kim
    Woo Chul Noh
    Eun Sook Lee
    Yong Sik Jung
    Lee Su Kim
    Wonshik Han
    Seok Jin Nam
    Gyung -Yub Gong
    Hwa Jung Kim
    Sei Hyun Ahn
    Breast Cancer Research, 22
  • [34] ASO Visual Abstract: Axillary Response to Neoadjuvant Therapy in Node-Positive ER+/HER2- Breast Cancer Patients—Predictors and Oncologic Outcomes
    Orli Friedman-Eldar
    Tolga Ozmen
    Salah James El Haddi
    Neha Goel
    Youley Tjendra
    Susan B. Kesmodel
    Mecker G. Moller
    Dido Franceschi
    Christina Layton
    Eli Avisar
    Annals of Surgical Oncology, 2022, 29 : 4102 - 4102
  • [35] erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer
    Paik, SM
    Bryant, J
    Park, CH
    Fisher, B
    Tan-Chiu, E
    Hyams, D
    Fisher, ER
    Lippman, ME
    Wickerham, DL
    Wolmark, N
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (18): : 1361 - 1370
  • [36] Age, Ki-67, Nodal Pathological Complete response and Overall Survival Following Neoadjuvant Chemotherapy for Node Positive Estrogen Receptor Positive, Her2 Negative Breast Cancer
    Moldoveanu, Dan
    Schulze, Amy
    Goetz, Matthew
    Hoskin, Tanya
    Day, Courtney
    Boughey, Judy C.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 1) : S96 - S96
  • [37] Improved Model for Predicting Axillary Response to Neoadjuvant Chemotherapy in Patients with Clinically Node-Positive Breast Cancer
    Kim, Hyung Suk
    Shin, Man Sik
    Kim, Chang Jong
    Yoo, Sun Hyung
    Yoo, Tae Kyung
    Eom, Yong Hwa
    Chae, Byung Joo
    Song, Byung Joo
    JOURNAL OF BREAST CANCER, 2017, 20 (04) : 378 - 385
  • [38] EFFECT OF ADJUVANT ENDOCRINE THERAPY ON ESTROGEN RECEPTOR-NEGATIVE, PROGESTERONE RECEPTOR-POSITIVE AND HER2 NEGATIVE BREAST CANCER PATIENTS
    Shen, Jun
    Wang, Lin-bo
    Teng, Rong-yue
    Shen, Jian-guo
    ACTA MEDICA MEDITERRANEA, 2022, 38 (03): : 1595 - 1600
  • [39] Pathological Prognostic Factors in Estrogen Receptor Positive/Her2 Negative and Lymph Node Negative Breast Cancers
    Mendoza, Pia
    Sonmez, Ceyda
    Zhang, Chao
    Neely, Cameron
    Liu, Yuan
    Li, Xiaoxian
    LABORATORY INVESTIGATION, 2017, 97 : 59A - 59A
  • [40] Pathological Prognostic Factors in Estrogen Receptor Positive/Her2 Negative and Lymph Node Negative Breast Cancers
    Mendoza, Pia
    Sonmez, Ceyda
    Zhang, Chao
    Neely, Cameron
    Liu, Yuan
    Li, Xiaoxian
    MODERN PATHOLOGY, 2017, 30 : 59A - 59A
12345